Eli Gilboa

SCHOOL OF MEDICINE, MICROBIOLOGY & IMMUNOLOGY

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

Eli Gilboa

• Departments
  SCHOOL OF MEDICINE
  
  MICROBIOLOGY & IMMUNOLOGY
  
  

  Current Appointments:

  Professor

  
  
  

3052431767

Available as Mentor - Not Indicated

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Eli Gilboa; James McNamara II; Fernando Pastor

  Use of oligonucleotide aptamer ligands to modulate the function of immune receptors

  Clinical Cancer Research. 2013;19(5):1054-1062.
  2

• 2.

  2012

  Thomas Blankenstein; Pierre G. Coulie; Eli Gilboa; Elizabeth M. Jaffee

  The determinants of tumour immunogenicity

  Nature Reviews Cancer. 2012;12(4):307-313.
  4

• 3.

  2012

  Eli Gilboa

  MRNA leapfrogs DNA to show promise for therapeutic gene transfer

  Molecular Therapy. 2012;20(4):694-695.
  0

• 4.

  2012

  Alexey Berezhnoy; C. Andrew Stewart; James O. Mcnamara II; William Thiel; Paloma Giangrande; Giorgio Trinchieri; Eli Gilboa

  Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing

  Molecular Therapy. 2012;20(6):1242-1250.
  4

• 5.

  2012

  Alexey Berezhnoy; Randall Brenneman; Marcio Bajgelman; Dawn Seales; Eli Gilboa

  Thermal stability of siRNA modulates aptamerconjugated siRNA inhibition

  Molecular Therapy - Nucleic Acids. 2012;1(10).
  1

• 6.

  2011

  Fernando Pastor; Despina Kolonias; James O. McNamara Ii; Eli Gilboa

  Targeting 4-1BB costimulation to disseminated tumor lesions with Bi-specific oligonucleotide aptamers

  Molecular Therapy. 2011;19(10):1878-1886.
  8

• 7.

  2010

  T. van Es; G.H.M. van Puijvelde; A.C. Foks; K.L.L. Habets; I. Bot; E. Gilboa; T.J.C. Van Berkel; J. Kuiper

  Vaccination against Foxp3⁺ regulatory T cells aggravates atherosclerosis

  Atherosclerosis. 2010;209(1):74-80.
  21

• 8.

  2010

  Fernando Pastor; Despina Kolonias; Paloma H. Giangrande; Eli Gilboa

  Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

  Nature. 2010;465(7295):227-230.
  44

• 9.

  2009

  Jing Zhou; Boonchoy Soontornworajit; Jacob Martin; Bruce A. Sullenger; Eli Gilboa; Yong Wang

  A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling

  Macromolecular Bioscience. 2009;9(9):831-835.
  8

• 10.

  2008

  James O. McNamara II; Despina Kolonias; Fernando Pastor; Robert S. Mittler; Lieping Chen; Paloma H. Giangrande; Bruce Sullenger; Eli Gilboa

  Multivalent 4-1BB binding aptamers costimulate CD8⁺ T cells and inhibit tumor growth in mice

  Journal of Clinical Investigation. 2008;118(1):376-386.
  75

• 11.

  2008

  Claudia M. Dollins; Smita Nair; David Boczkowski; Jaewoo Lee; Juliana M. Layzer; Eli Gilboa; Bruce A. Sullenger

  Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer

  Chemistry and Biology. 2008;15(7):675-682.
  36

• 12.

  2007

  Smita Nair; David Boczkowski; Martin Fassnacht; David Pisetsky; Eli Gilboa

  Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity

  Cancer Research. 2007;67(1):371-380.
  75

• 13.

  2007

  Eli Gilboa

  DC-based cancer vaccines

  Journal of Clinical Investigation. 2007;117(5):1195-1203.
  258

• 14.

  2007

  Nada M. Melhem; Xiang Dong Liu; David Boczkowski; Eli Gilboa; Simon M. Barratt-Boyes

  Robust CD4⁺ and CD8⁺ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag

  European Journal of Immunology. 2007;37(8):2164-2173.
  16

• 15.

  2006

  Peter E Fecci; Alison E Sweeney; Peter M Grossi; Smita K Nair; Christopher A Learn; Duane A Mitchell; Xiuyu Cui; Thomas J Cummings; Darell D Bigner; Eli Gilboa; et al.

  Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research. 2006;12(14 Pt 1):4294-4305.
  66

• 16.

  2006

  Daniel G. Kavanagh; Daniel E. Kaufmann; Sherzana Sunderji; Nicole Frahm; Sylvie Le Gall; David Boczkowski; Eric S. Rosenberg; David R. Stone; Mary N. Johnston; Bradford S. Wagner; et al.

  Expansion of HIV-specific CD4⁺ and CD8⁺ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

  Blood. 2006;107(5):1963-1969.
  34

• 17.

  2006

  Paul R. Hess; David Boczkowski; Smita K. Nair; David Snyder; Eli Gilboa

  Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen

  Cancer Immunology, Immunotherapy. 2006;55(6):672-683.
  22

• 18.

  2006

  James O. McNamara II; Eran R. Andrechek; Yong Wang; Kristi D. Viles; Rachel E. Rempel; Eli Gilboa; Bruce A. Sullenger; Paloma H. Giangrande

  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

  Nature Biotechnology. 2006;24(8):1005-1015.
  349

• 19.

  2005

  Zhen Su; Jens Dannull; Benjamin K. Yang; Philipp Dahm; Doris Coleman; Donna Yancey; Sylvia Sichi; Donna Niedzwiecki; David Boczkowski; Eli Gilboa; et al.

  Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8⁺ and CD4⁺ T cell responses in patients with metastatic prostate cancer

  Journal of Immunology. 2005;174(6):3798-3807.
  181

• 20.

  2005

  Martin Fassnacht; Jaewoo Lee; Caterina Milazzo; David Boczkowski; Zhen Su; Smita Nair; Eli Gilboa

  Induction of CD4⁺ and CD8⁺ T-cell responses to the human stromal antigen, fibroblast activation protein: Implication for cancer immunotherapy

  Clinical Cancer Research. 2005;11(15):5566-5571.
  27

• 21.

  2005

  Jaewoo Lee; Martin Fassnacht; Smita Nair; David Boczkowski; Eli Gilboa

  Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

  Cancer Research. 2005;65(23):11156-11163.
  45

• 22.

  2005

  Jens Dannull; Zhen Su; David Rizzieri; Benjamin K. Yang; Doris Coleman; Donna Yancey; Aijing Zhang; Philipp Dahm; Nelson Chao; Eli Gilboa; et al.

  Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

  Journal of Clinical Investigation. 2005;115(12):3623-3633.
  565

• 23.

  2005

  Jens Dannull; Smita Nair; Zhen Su; David Boczkowski; Christian DeBeck; Benjamin Yang; Eli Gilboa; Johannes Vieweg

  Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand

  Blood. 2005;105(8):3206-3213.
  57

• 24.

  2004

  Eli Gilboa

  The promise of cancer vaccines

  Nature Reviews Cancer. 2004;4(5):401-411.
  165

• 25.

  2004

  Xinsheng Liao; Yongqing Li; Chiara Bonini; Smita Nair; Eli Gilboa; Philip D. Greenberg; Cassian Yee

  Transfection of RNA encoding tumor antigens following maturation of dendritic cells and to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes

  Molecular Therapy. 2004;9(5):757-764.
  29

• 26.

  2004

  Robin M. Cisco; Zeinab Abdel-Wahab; Jens Dannull; Smita Nair; Douglas S. Tyler; Eli Gilboa; Johannes Vieweg; Yehia Daaka; Scott K. Pruitt

  Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4

  Journal of Immunology. 2004;172(11):7162-7168.
  34

• 27.

  2004

  Eli Gilboa; Johannes Vieweg

  Cancer immunotherapy with mRNA-transfected dendritic cells

  Immunological Reviews. 2004;199:251-263.
  160

• 28.

  2004

  Eli Gilboa

  Knocking the SOCS1 off dendritic cells

  Nature Biotechnology. 2004;22(12):1521-1522.
  3

• 29.

  2003

  Smita Nair; Catherine McLaughlin; Alon Weizer; Zhen Su; David Boczkowski; Jens Dannull; Johannes Vieweg; Eli Gilboa

  Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation

  Journal of Immunology. 2003;171(11):6275-6282.
  104

• 30.

  2003

  Zhen Su; Jens Dannull; Axel Heiser; Donna Yancey; Scott Pruitt; John Madden; Doris Coleman; Donna Niedzwiecki; Eli Gilboa; Johannes Vieweg

  Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

  Cancer Research. 2003;63(9):2127-2133.
  218

• 31.

  2003

  Michael A. Morse; Smita K. Nair; Paul J. Mosca; Amy C. Hobeika; Timothy M. Clay; Yuping Deng; David Boczkowski; Alan Proia; Donna Neidzwiecki; Pierre-A. Clavien; et al.

  Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA

  Cancer Investigation. 2003;21(3):341-349.
  81

• 32.

  2003

  Smita Nair; David Boczkowski; Benjamin Moeller; Mark Dewhirst; Johannes Vieweg; Eli Gilboa

  Synergy between tumor immunotherapy and antiangiogenic therapy

  Blood. 2003;102(3):964-971.
  101

• 33.

  2003

  Sandra Santulli-Marotto; Smita K. Nair; Chris Rusconi; Bruce Sullenger; Eli Gilboa

  Multivalent RNA Aptamers That Inhibit CTLA-4 and Enhance Tumor Immunity

  Cancer Research. 2003;63(21):7483-7489.
  62

• 34.

  2003

  Yangbing Zhao; David Boczkowski; Smita K. Nair; Eli Gilboa

  Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4⁺ T-cell responses and tumor immunity

  Blood. 2003;102(12):4137-4142.
  22

• 35.

  2002

  Michael A. Morse; Smita K. Nair; David Boczkowski; Douglas Tyler; Herbert I. Hurwitz; Alan Proia; Timothy M. Clay; Jeffrey Schlom; Eli Gilboa; et al.

  The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer

  International Journal of Gastrointestinal Cancer. 2002;32(1):1-6.
  34

• 36.

  2002

  Brenda Faiola; Carolyn Doyle; Eli Gilboa; Smita Nair

  Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells

  Immunology. 2002;105(1):47-55.
  7

• 37.

  2002

  Axel Heiser; Doris Coleman; Jens Dannull; Donna Yancey; Margaret A. Maurice; Costas D. Lallas; Philipp Dahm; Donna Niedzwiecki; Eli Gilboa; Johannes Vieweg

  Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

  Journal of Clinical Investigation. 2002;109(3):409-417.
  334

• 38.

  2002

  Smita K. Nair; Michael Morse; David Boczkowski; R. Ian Cumming; Ljiljana Vasovic; Eli Gilboa; H. Kim Lyerly

  Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells

  Annals of Surgery. 2002;235(4):540-549.
  114

• 39.

  2002

  B. Faiola; C. Doyle; E. Gilboa; S. Nair

  Erratum: Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells (Immunology (2002) 105 (47-55))

  Immunology. 2002;106(1):122-123.
  1

• 40.

  2002

  Zhen Su; Johannes Vieweg; Alon Z. Weizer; Philipp Dahm; Donna Yancey; Vandana Turaga; John Higgins; David Boczkowski; Eli Gilboa; Jens Dannull

  Enhanced induction of telomerase-specific CD4⁺ T cells using dendritic cells transfected with RNA encoding a chimeric gene product

  Cancer Research. 2002;62(17):5041-5048.
  81

• 41.

  2002

  Bruce A. Sullenger; Eli Gilboa

  Emerging clinical applications of RNA

  Nature. 2002;418(6894):252-258.
  197

• 42.

  2001

  A. Heiser; M.A. Maurice; D.R. Yancey; N.Z. Wu; P. Dahm; S.K. Pruitt; D. Boczkowski; S.K. Nair; M.S. Ballo; et al.

  Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA

  Journal of Immunology. 2001;166(5):2953-2960.
  147

• 43.

  2001

  Eli Gilboa

  The risk of autoimmunity associated with tumor immunotherapy

  Nature Immunology. 2001;2(9):789-792.
  65

• 44.

  2001

  Jun-Ichi Nishimura; Ken L. Phillips; Russell E. Ware; Sharon Hall; Lee Wilson; Tracy L. Gentry; Thad A. Howard; Yoshiko Murakami; Masaru Shibano; Takashi Machii; et al.

  Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype

  Blood. 2001;97(10):3004-3010.
  16

• 45.

  2000

  Smita K. Nair; Axel Heiser; David Boczkowski; Anish Majumdar; Michio Naoe; Jane S. Lebkowski; Johannes Vieweg; Eli Gilboa

  Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells

  Nature Medicine. 2000;6(9):1011-1017.
  258

• 46.

  2000

  William A. Larchian; Yutaka Horiguchi; Smita K. Nair; William R. Fair; Warren D. W. Heston; Eli Gilboa

  Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: A liposome-mediated gene therapy treatment for bladder cancer

  Clinical Cancer Research. 2000;6(7):2913-2920.
  21

• 47.

  2000

  Courtney Thornburg; David Boczkowski; Eli Gilboa; Smita K. Nair

  Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: Implications for cervical cancer immunotherapy

  Journal of Immunotherapy. 2000;23(4):412-418.
  45

• 48.

  2000

  Yuzo Kodaira; Smita K. Nair; Lucile E. Wrenshall; Eli Gilboa; Jeffrey L. Platt

  Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate

  Journal of Immunology. 2000;165(3):1599-1604.
  77

• 49.

  2000

  David Boczkowski; Smita K. Nair; Jong-Hee Nam; H. Kim Lyerly; Eli Gilboa

  Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells

  Cancer Research. 2000;60(4):1028-1034.
  221

• 50.

  2000

  Axel Heiser; Philipp Dahm; Donna R. Yancey; Margaret A. Maurice; David Boczkowski; Smita K. Nair; Eli Gilboa; Johannes Vieweg

  Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro

  Journal of Immunology. 2000;164(10):5508-5514.
  151

• 51.

  1999

  Eli Gilboa

  How tumors escape immune destruction and what we can do about it

  Cancer Immunology Immunotherapy. 1999;48(7):382-385.
  99

• 52.

  1999

  Smita Nair; Pamela A. Wearsch; Duane A. Mitchell; James J. Wassenberg; Eli Gilboa; Christopher V. Nicchitta

  Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides

  Journal of Immunology. 1999;162(11):6426-6432.
  77

• 53.

  1999

  Eli Gilboa

  The makings of a tumor rejection antigen

  Immunity. 1999;11(3):263-270.
  244

• 54.

  1999

  Smita K. Nair; Shelley Hull; Doris Coleman; Eli Gilboa; H. Kim Lyerly; Michael A. Morse

  Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T- lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA

  International Journal of Cancer. 1999;82(1):121-124.
  127

• 55.

  1998

  D.A. Mitchell; S.K. Nair; E. Gilboa

  Correction: Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells (European Journal of Immunology (1998) 28, 6 (1923-1933))

  European Journal of Immunology. 1998;28(11):3891.
  2

• 56.

  1998

  Duane A. Mitchell; Smita K. Nair; Eli Gilboa

  Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells

  European Journal of Immunology. 1998;28(6):1923-1933.
  68

• 57.

  1998

  Smita K. Nair; David Boczkowski; Michael Morse; R. Ian Cumming; H. Kim Lyerly; Eli Gilboa

  Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

  Nature Biotechnology. 1998;16(4):364-369.
  305

• 58.

  1998

  G.B. McCowage; K.L. Phillips; T.L. Gentry; S. Hull; J. Kurtzberg; E. Gilboa; C. Smith

  Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells

  Experimental Hematology. 1998;26(4):288-298.
  23

• 59.

  1998

  Eli Gilboa; Smita K. Nair; H. Kim Lyerly

  Immunotherapy of cancer with dendritic-cell-based vaccines

  Cancer Immunology Immunotherapy. 1998;46(2):82-87.
  234

• 60.

  1998

  Michael A. Morse; H. Kim Lyerly; Eli Gilboa; Elaine Thomas; Smita K. Nair

  Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells

  Cancer Research. 1998;58(14):2965-2968.
  70

• 61.

  1998

  Seong-Wook Lee; Eli Gilboa

  High Level Accumulation of an Aberrantly Spliced Human DHFR RNA Species

  Molecules and Cells. 1998;8(2):189-200.
  3

• 62.

  1998

  Y. Kodaira; L.E. Wrenshall; S. Nair; E. Gilboa; J.L. Platt

  Heparan sulfate modulate allogeneic T cell responses stimulated by dendritic cells

  FASEB Journal. 1998;12(4):A582.
  1

• 63.

  1997

  David M. Ashley; Brenda Faiola; Smita Nair; Laura P. Hale; Darell D. Bigner; Eli Gilboa

  Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

  Journal of Experimental Medicine. 1997;186(7):1177-1182.
  326

• 64.

  1997

  Smita K. Nair; David Snyder; Barry T. Rouse; Eli Gilboa

  Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

  International Journal of Cancer. 1997;70(6):706-715.
  171

• 65.

  1997

  Smita K. Nair; David Boczkowski; David Snyder; Eli Gilboa

  Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines

  European Journal of Immunology. 1997;27(3):589-597.
  82

• 66.

  1997

  Bryan M. Clary; Eamonn C. Coveney; Ramila Philip; Dan G. Blazer III; Michael Morse; Eli Gilboa; H. Kim Lyerly

  Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells

  Cancer Gene Therapy. 1997;4(2):97-104.
  29

• 67.

  1997

  Bryan M. Clary; Eamonn C. Coveney; Dan G. Blazer III; Ramila Philip; Mohan Philip; Michael Morse; Eli Gilboa; H. Kim Lyerly

  Active immunization with tumor cells transduced by a novel AAV plasmid- based gene delivery system

  Journal of Immunotherapy. 1997;20(1):26-37.
  6

• 68.

  1997

  Angel Porgador; Herman F. Staats; Brenda Faiola; Eli Gilboa; Thomas J. Palker

  Intranasal Immunization with CTL Epitope Peptides from HIV-1 or Ovalbumin and the Mucosal Adjuvant Cholera Toxin Induces Peptide-Specific CTLs and Protection Against Tumor Development in Vivo

  Journal of Immunology. 1997;158(2):834-841.
  87

• 69.

  1996

  T. Rudoll; K. Phillips; S.-W. Lee; S. Hull; O. Gaspar; N. Sucgang; E. Gilboa; C. Smith

  High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4⁺ T lymphocytes

  Gene Therapy. 1996;3(8):695-705.
  48

• 70.

  1996

  K. Phillips; T. Gentry; G. McCowage; E. Gilboa; C. Smith

  Cell-surface markers for assessing gene transfer into human hematopoietic cells

  Nature Medicine. 1996;2(10):1154-1155.
  39

• 71.

  1996

  David Boczkowski; Smita K. Nair; David Snyder; Eli Gilboa

  Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

  Journal of Experimental Medicine. 1996;184(2):465-472.
  602

• 72.

  1996

  E. Gilboa

  Immunotherapy of cancer with genetically modified tumor vaccines

  Seminars in Oncology. 1996;23(1):101-107.
  73

• 73.

  1996

  S.K. Nair; D. Snyder; E. Gilboa

  Cells treated with TAP-2 antisense oligonucleotides are potent antigen- presenting cells in vitro and in vivo

  Journal of Immunology. 1996;156(5):1772-1780.
  7

• 74.

  1996

  Clay Smith; Seong-Wook Lee; Ellen Wong; Humilidad Gallardo; Kevin Page; Ofelia Gaspar; Jane Lebkowski; Eli Gilboa

  Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys

  Antiviral Research. 1996;32(2):99-115.
  17

• 75.

  1996

  Angel Porgador; David Snyder; Eli Gilboa

  Induction of antitumor immunity using bone marrow-generated dendritic cells

  Journal of Immunology. 1996;156(8):2918-2926.
  291

• 76.

  1996

  H.F. Staats; A. Porgador; B. Faiola; E. Gilboa; T.J. Palker

  Induction of cytotoxic T lymphocytes (CTL) specific for HIV-1 or protection against tumor challenge by intranasal immunization with CTL peptide and cholera toxin

  FASEB Journal. 1996;10(6):A1191.
  0

• 77.

  1995

  J. Tjuvajev; B. Gansbacher; R. Desai; B. Beattie; M. Kaplitt; C. Matei; J. Koutcher; E. Gilboa; R. Blasberg

  RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-γ

  Cancer Research. 1995;55(9):1902-1910.
  90

• 78.

  1995

  J. Vieweg; E. Gilboa

  Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment

  Cancer Investigation. 1995;13(2):193-201.
  36

• 79.

  1995

  Angel Porgador; Eli Gilboa

  Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

  Journal of Experimental Medicine. 1995;182(1):255-260.
  329

• 80.

  1995

  J. Vieweg; D. Boczkowski; K.M. Roberson; D.W. Edwards; M. Philip; R. Philip; T. Rudoll; C. Smith; C. Robertson; E. Gilboa

  Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer

  Cancer Research. 1995;55(11):2366-2372.
  73

• 81.

  1995

  S.-W. Lee; E. Gilboa; C. Smith

  Inhibition of HIV-1 with minimal Rev responsive element (RRE) decoys

  International Antiviral News. 1995;3(6):89-90.
  0

• 82.

  1995

  S.-W. Lee; H.F. Gallardo; O. Gaspar; C. Smith; E. Gilboa

  Inhibition of HIV-1 in CEM cells by a potent TAR decoy

  Gene Therapy. 1995;2(6):377-384.
  47

• 83.

  1995

  J. Vieweg; E. Gilboa

  Gene therapy approaches in urologic oncology.

  Surgical oncology clinics of North America. 1995;4(2):203-218.
  6

• 84.

  1995

  C. Smith; S.-W. Lee; E. Gilboa

  Inhibition of HIV-1 with intracellular immunization with RNA decoys

  Advanced Drug Delivery Reviews. 1995;17(3):369-371.
  0

• 85.

  1994

  Seong-Wook Lee; Humilidad F. Gallardo; Eli Gilboa; Clay Smith

  Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain

  Journal of Virology. 1994;68(12):8254-8264.
  93

• 86.

  1994

  Rajat Bannerji; Crispinita D. Arroyo; Carlos Cordon-Cardo; Eli Gilboa

  The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity

  Journal of Immunology. 1994;152(5):2324-2332.
  76

• 87.

  1994

  J. Vieweg; W.D.W. Heston; E. Gilboa; W.R. Fair

  An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer

  Prostate. 1994;24(6):291-298.
  19

• 88.

  1994

  Johannes Vieweg; Felicia M. Rosenthal; Rajat Bannerji; Warren D. W. Heston; William R. Fair; Bernd Gansbacher; Eli Gilboa

  Immunotherapy of prostate cancer in the dunning rat model: Use of cytokine gene modified tumor vaccines

  Cancer Research. 1994;54(7):1760-1765.
  159

• 89.

  1994

  Ming-Xia Li; Debabrata Banerjee; Shi-Cheng Zhao; Barry I. Schweitzer; Shin Mineishi; Eli Gilboa; Joseph R. Bertino

  Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction

  Blood. 1994;83(11):3403-3408.
  59

• 90.

  1994

  Shiro Saito; Rajat Bannerji; Bernd Gansbacher; Felicia M. Rosenthal; Peter Romanenko; Warren D. W. Heston; William R. Fair; Eli Gilboa

  Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines

  Cancer Research. 1994;54(13):3516-3520.
  93

• 91.

  1994

  Eli Gilboa; Clay Smith

  Gene therapy for infectious diseases: The AIDS model

  Trends in Genetics. 1994;10(4):139-144.
  63

• 92.

  1994

  S.C. Zhao; M.X. Li; D. Banerjee; B.I. Schweitzer; S. Mineishi; E. Gilboa; J.R. Bertino

  Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.

  Cancer gene therapy. 1994;1(1):27-33.
  56

• 93.

  1994

  Eli Gilboa; H.K. Lyerly; Johannes Vieweg; Shiro Saito

  Immunotherapy of cancer using cytokine gene-modified tumor vaccines

  Seminars in Cancer Biology. 1994;5(6):409-417.
  34

• 94.

  1993

  J. Connor; R. Bannerji; S. Saito; W. Heston; W. Fair; E. Gilboa

  Erratum: Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells (Journal of Experimental Medicine (April 1993) 177 (1127))

  Journal of Experimental Medicine. 1993;177(6):1833.
  0

• 95.

  1993

  A. Porgador; R. Bannerji; Y. Watanabe; M. Feldman; E. Gilboa; L. Eisenbach

  Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells

  Journal of Immunology. 1993;150(4):1458-1470.
  105

• 96.

  1993

  A. Porgador; B. Gansbacher; R. Bannerji; E. Tzehoval; E. Gilboa; M. Feldman; L. Eisenbach

  Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells

  International Journal of Cancer. 1993;53(3):471-477.
  78

• 97.

  1993

  Clay Smith; Marcus O. Muench; Marianne Knizewski; Eli Gilboa; Malcolm A.S. Moore

  Development of a lacZ marked WEHI-3B D⁺ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia

  Leukemia. 1993;7(2):310-317.
  7

• 98.

  1993

  J. Connor; R. Bannerji; S. Saito; W. Heston; W. Fair; E. Gilboa

  Regression of bladder tumors in mice treated with interleukin 2 gene- modified tumor cells

  Journal of Experimental Medicine. 1993;177(4):1127-1134.
  164

• 99.

  1993

  L.L. Chen; B. Gansbacher; E. Gilboa; R. Taetle; J. Oval; M.S. Hibbs; C.K. Huang; M.L. Clawson; S. Bilgrami; J. Schlessinger

  Retroviral gene transfer of epidermal growth factor receptor into HL60 cells results in a partial block of retinoic acid-induced granulocytic differentiation.

  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 1993;4(9):769-776.
  11

• 100.

  1993

  Claudio Bordignon; Fulvio Mavilio; Giuliana Ferrari; Paolo Servida; Alberto G. Ugazio; Luigi D. Notarangelo; Eli Gilboa

  Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID

  Human Gene Therapy. 1993;4(4):513-520.
  19

• 101.

  1992

  G. Gastl; C.L. Finstad; A. Guarini; G. Bosl; E. Gilboa; N.H. Bander; B. Gansbacher

  Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells

  Cancer Research. 1992;52(22):6229-6236.
  54

• 102.

  1992

  B. Gansbacher; K. Zier; K. Cronin; P.A. Hantzopoulos; B. Bouchard; A. Houghton; E. Gilboa; D. Golde

  Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-γ in irradiated human melanoma cells

  Blood. 1992;80(11):2817-2825.
  64

• 103.

  1992

  T.C. Lee; B.A. Sullenger; H.F. Gallardo; G.E. Ungers; E. Gilboa

  Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells

  New Biologist. 1992;4(1):66-74.
  69

• 104.

  1992

  M. Suchi; T. Dinur; R.J. Desnick; S. Gatt; L. Pereira; E. Gilboa; E.H. Schuchman

  Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: Correction of the metabolic defect in cultured Niemann-Pick disease cells

  Proceedings of the National Academy of Sciences of the United States of America. 1992;89(8):3227-3231.
  16

• 105.

  1992

  M. Li; P.A. Hantzopoulos; D. Banerjee; S.C. Zhao; B.I. Schweitzer; E. Gilboa; J.R. Bertino

  Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors

  Human Gene Therapy. 1992;3(4):381-390.
  35

• 106.

  1991

  G. Ferrari; S. Rossini; R. Giavazzi; D. Maggioni; N. Nobili; M. Soldati; G. Ungers; F. Mavilio; E. Gilboa; et al.

  An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency

  Science. 1991;251(4999):1363-1366.
  44

• 107.

  1991

  B.A. Sullenger; H.F. Gallardo; G.E. Ungers; E. Gilboa

  Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation

  Journal of Virology. 1991;65(12):6811-6816.
  80

• 108.

  1991

  James V. Fetten; Nita Roy; Eli Gilboa

  A frameshift mutation at the NH₂ terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes

  Journal of Immunology. 1991;147(8):2697-2705.
  22

• 109.

  1991

  J. Oval; R. Hershberg; B. Gansbacher; E. Gilboa; J. Schlessinger; R. Taetle

  Expression of functional epidermal growth factor receptors in a human hematopoietic cell line

  Cancer Research. 1991;51(1):150-156.
  1

• 110.

  1990

  E. Gilboa

  Retroviral gene transfer: applications to human therapy.

  Progress in clinical and biological research. 1990;352:301-311.
  16

• 111.

  1990

  B. Gansbacher; K. Zier; B. Daniels; K. Cronin; R. Bannerji; E. Gilboa

  Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

  Journal of Experimental Medicine. 1990;172(4):1217-1224.
  395

• 112.

  1990

  B.A. Sullenger; H.F. Gallardo; G.E. Ungers; E. Gilboa

  Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

  Cell. 1990;63(3):601-608.
  227

• 113.

  1990

  B.A. Sullenger; T.C. Lee; C.A. Smith; G.E. Ungers; E. Gilboa

  Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication

  Molecular and Cellular Biology. 1990;10(12):6512-6523.
  53

• 114.

  1990

  J.H. Wolfe; E.H. Schuchman; L.E. Stramm; E.A. Concaugh; M.E. Haskins; G.D. Aguirre; D.F. Patterson; R.J. Desnick; E. Gilboa

  Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer

  Proceedings of the National Academy of Sciences of the United States of America. 1990;87(8):2877-2881.
  36

• 115.

  1990

  B. Gansbacher; R. Bannerji; B. Daniels; K. Zier; K. Cronin; E. Gilboa

  Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity

  Cancer Research. 1990;50(24):7820-7825.
  234

• 116.

  1989

  C. Bordignon; S.-F. Yu; C.A. Smith; P. Hantzopoulos; G.E. Ungers; C.A. Keever; R.J. O'Reilly; E. Gilboa

  Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells

  Proceedings of the National Academy of Sciences of the United States of America. 1989;86(17):6748-6752.
  17

• 117.

  1989

  P.W. Kantoff; A.W. Flake; M.A. Eglitis; S. Scharf; S. Bond; E. Gilboa; H. Erlich; M.R. Harrison; E.D. Zanjani; W.F. Anderson

  In utero gene transfer and expression: A sheep transplantation model

  Blood. 1989;73(4):1066-1073.
  26

• 118.

  1989

  T. Von Ruden; E. Gilboa

  Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA

  Journal of Virology. 1989;63(2):677-682.
  12

• 119.

  1989

  P.A. Hantzopoulos; B.A. Sullenger; G. Ungers; E. Gilboa

  Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.

  Proceedings of the National Academy of Sciences of the United States of America. 1989;86(10):3519-3523.
  108

• 120.

  1988

  E. Gilboa

  Retroviral gene transfer: applications to human therapy.

  Advances in experimental medicine and biology. 1988;241:29-33.
  0

• 121.

  1988

  L.H. Hwang; E. Gilboa

  Intron sequences may influence the efficiency and correctness in selecting a 3'-splicing acceptor site.

  Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association. 1988;87(12):1141-1148.
  0

• 122.

  1987

  J.A. Rasmussen; E. Gilboa

  Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector

  Journal of Virology. 1987;61(5):1368-1374.
  2

• 123.

  1987

  D. Armentano; S.-F. Yu; P.W. Kantoff; T. von Ruden; W.F. Anderson; E. Gilboa

  Effect of internal viral sequences on the utility of retroviral vectors

  Journal of Virology. 1987;61(5):1647-1650.
  98

• 124.

  1987

  A. Gillio; C. Bordignon; N. Kernan; P. Kantoff; M. Eglitis; J. McLachlin; E. Karson; S.F. Yu; J. Zwiebel; A. Nienhuis; et al.

  Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation

  Annals of the New York Academy of Sciences. 1987;511:406-417.
  1

• 125.

  1986

  W.F. Anderson; P.W. Kantoff; M.A. Eglitis; E. Gilboa

  Gene transfer into animals by retroviral vectors.

  Basic life sciences. 1986;37:59-65.
  1

• 126.

  1986

  E. Gilboa

  Retrovirus vectors and their uses in molecular biology.

  BioEssays. 1986;5(6):252-257.
  4

• 127.

  1986

  E. Gilboa; M.A. Eglitis; P.W. Kantoff; W.F. Anderson

  Transfer and expression of cloned genes using retroviral vectors

  BioTechniques. 1986;4(6):504-512.
  39

• 128.

  1986

  L. Wolff; J.F. Mushinski; E. Gilboa; H.C. Morse 3rd.

  Induction of hematopoietic tumors using a viral construct containing c-myc cDNA from normal mouse spleen.

  Current Topics in Microbiology and Immunology. 1986;132:33-39.
  2

• 129.

  1986

  S.-F. Yu; T. von Ruden; P.W. Kantoff; C. Garber; M. Seiberg; U. Rüther; W.F. Anderson; E.F. Wagner; E. Gilboa

  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

  Proceedings of the National Academy of Sciences of the United States of America. 1986;83(10):3194-3198.
  216

• 130.

  1985

  M. Taketo; E. Gilboa; M.I. Sherman

  Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the Moloney murine leukemia virus long terminal repeat

  Proceedings of the National Academy of Sciences of the United States of America. 1985;82(8):2422-2426.
  1

• 131.

  1985

  E.F. Wagner; G. Keller; E. Gilboa; U. Rüther; C. Stewart

  Gene transfer into murine stem cells and mice using retroviral vectors.

  Cold Spring Harbor symposia on quantitative biology. 1985;50:691-700.
  1

• 132.

  1985

  G. Keller; C. Paige; E. Gilboa; E.F. Wagner

  Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors

  Nature. 1985;318(6042):149-154.
  118

• 133.

  1985

  M.A. Eglitis; P. Kantoff; E. Gilboa; W.F. Anderson

  Gene expression in mice after high efficiency retroviral-mediated gene transfer

  Science. 1985;230(4732):1395-1398.
  51

• 134.

  1984

  L.-H.S. Hwang; E. Gilboa

  Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection

  Journal of Virology. 1984;50(2):417-424.
  24

• 135.

  1984

  J.J. Champoux; E. Gilboa; D. Baltimore

  Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase

  Journal of Virology. 1984;49(3):686-691.
  21

• 136.

  1984

  L.-H.S. Hwang; J. Park; E. Gilboa

  Role of intron-contained sequences in formation of Moloney murine leukemia virus env mRNA

  Molecular and Cellular Biology. 1984;4(11):2289-2297.
  3

• 137.

  1982

  E. Gilboa; M. Kolbe; K. Noonan; R. Kucherlapati

  Construction of a mammalian transducing vector from the genome of Moloney murine leukemia virus

  Journal of Virology. 1982;44(3):845-851.
  3

• 138.

  1981

  C. Shoemaker; S. Goff; E. Gilboa; M. Paskind; S.W. Mitra; D. Baltimore

  Structure of cloned retroviral circular DNAs: implications for virus integration.

  Cold Spring Harbor Symposia on Quantitative Biology. 1981;45 Pt 2:711-717.
  2

• 139.

  1981

  S.P. Goff; O.N. Witte; E. Gilboa; N. Rosenberg; D. Baltimore

  Genome structure of Abelson murine leukemia virus variants: Proviruses in fibroblasts and lymphoid cells

  Journal of Virology. 1981;38(2):460-468.
  4

• 140.

  1980

  S.P. Goff; E. Gilboa; O.N. Witte; D. Baltimore

  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA

  Cell. 1980;22(3):777-785.
  69

• 141.

  1980

  C. Shoemaker; S. Goff; E. Gilboa; M. Paskind; S.W. Mitra; D. Baltimore

  Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: Implications for retrovirus integration

  Proceedings of the National Academy of Sciences of the United States of America. 1980;77(7 II):3932-3936.
  46

• 142.

  1979

  D. Baltimore; E. Gilboa; E. Rothenberg; F. Yoshimura

  Production of a discrete, infectious, double-stranded DNA by reverse transcription in virions of Moloney murine leukemia virus

  Cold Spring Harbor Symposia on Quantitative Biology. 1979;43(2):869-874.
  0

• 143.

  1979

  S.W. Mitra; S. Goff; E. Gilboa; D. Baltimore

  Synthesis of a 600-nucleotide-long plus-strand DNA by virions of Moloney murine leukemia virus

  Proceedings of the National Academy of Sciences of the United States of America. 1979;76(9):4355-4359.
  9

• 144.

  1979

  E. Gilboa; S.W. Mitra; S. Goff; D. Baltimore

  A detailed model of reverse transcription and tests of crucial aspects

  Cell. 1979;18(1):93-100.
  213

• 145.

  1979

  E. Gilboa; S. Goff; A. Shields; F. Yoshimura; S. Mitra; D. Baltimore

  In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus

  Cell. 1979;16(4):863-874.
  17

• 146.

  1978

  Yoram Groner; Eli Gilboa; Haim Aviv

  Methylation and capping of RNA polymerase II primary transcripts by HeLa nuclear homogenates

  Biochemistry. 1978;17(6):977-982.
  0

• 147.

  1977

  C. Prives; E. Gilboa; M. Revel; E. Winocour

  Cell free translation of simian virus 40 early messenger RNA coding for viral T antigen

  Proceedings of the National Academy of Sciences of the United States of America. 1977;74(2):457-461.
  1

• 148.

  1977

  E. Gilboa; H. Soreq; H. Aviv

  Initiation of RNA synthesis in isolated nuclei

  European Journal of Biochemistry. 1977;77(2):393-400.
  0

• 149.

  1976

  E. Gilboa; H. Aviv

  Preferential synthesis of viral late RNA by nuclei isolated from SV40 lytically infected cells

  Cell. 1976;7(4):567-573.
  0

• 150.

  1975

  Eli Gilboa; Carol L. Prives; Haim Aviv

  Purification of SV-40 messenger RNA by hybridization to SV-40 DNA covalently bound to sepharose

  Biochemistry. 1975;14(19):4215-4220.
  0

• 151.

  1975

  C. Prives; E. Gilboa; H. Aviv; M. Revel; E. Winocour

  Proceedings: Purification and translation of mRNA coding for SV40 proteins.

  Israel Journal of Medical Sciences. 1975;11(11):1206.
  0

• 152.

  1974

  C.L. Prives; H. Aviv; E. Gilboa; M. Revel; E. Winocour

  The cell free translation of SV40 messenger RNA

  Symposia on Quantitative Biology. 1974;39(1):309-316.
  0

• 153.

  1973

  E. Gilboa; Y. Elkana; M. Rigbi

  Purification and properties of human acrosin

  European Journal of Biochemistry. 1973;39(1):85-92.
  2